INVITRO is an independent laboratory offering over 1000 types of research, effectively helping doctors and patients take care of their health throughout their lives. The company's quality management system complies with the requirements of ISO 15189:2007 and ISO 9001:2008, ensuring high standards in medical laboratory services. Established in 1995, INVITRO was among the first in the medical services market to employ a network business model, with over 300 medical offices across Russia, operating under the trademarks INVITRO® or INVITRO®. The company operates four technological complexes in Moscow, St. Petersburg, Chelyabinsk, and Novosibirsk, and one in Ukraine. With a multi-level quality control system and test systems from leading global manufacturers, INVITRO's research results are recognized by all medical institutions in Russia. The company operates in the Health Care industry and has not disclosed its last investment or investors yet.
There is no investment information